Dubinski I, Bechtold-Dalla Pozza S, Bidlingmaier M, Hawley J, Keevil B, Kunz S, Nowotny HF, Reisch N, Schiergens K, Tschaidse L, Schmidt H. Diurnal 11-ketotestosterone and 17-hydroxyprogesterone saliva profiles in paediatric classical congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2024 Apr 2;37(5):419-424. doi: 10.1515/jpem-2024-0027. PMID: 38557593.
Kunz S, Meng Y, Schneider H, Brunnenkant L, Höhne M, Kühnle T, Reincke M, Theodoropoulou M, Bidlingmaier M. Fast and reliable quantification of aldosterone, cortisol and cortisone via LC-MS/MS to study 11β-hydroxysteroid dehydrogenase activities in primary cell cultures. J Steroid Biochem Mol Biol. 2024 Nov;244:106610. doi: 10.1016/j.jsbmb.2024.106610. Epub 2024 Aug 28. PMID: 39214289.
Nowotny HF, Zheng T, Seiter TM, Ju J, Schneider H, Kroiss M, Sarkis AL, Sturm L, Britz V, Lechner A, Potzel AL, Kunz S, Bidlingmaier M, Neuhaus K, Gottschlich A, Kobold S, Reisch N, Schirmer M, Reincke M, Adolf C. Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronism. Front Immunol. 2024 Dec 19;15:1428054. doi: 10.3389/fimmu.2024.1428054. PMID: 39749333; PMCID: PMC11693743.
Auer MK, Büyükerzurmulu D, Lottspeich C, Bidlingmaier M, Rieger E, Nowotny H, Tschaidse L, Auchus RJ, Reisch N. Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years. Eur J Endocrinol. 2024 Aug 30;191(3):370-380. doi: 10.1093/ejendo/lvae112. PMID: 39308408
Auer MK, Minea CE, Quinkler M, Bancos I, Beuschlein F, Meyer G, Lottspeich C, Bidlingmaier M, Rieger E, Nowotny HF, Tschaidse L, Falhammar H, Pivonello R, Simeoli C, Reisch N. Women With Congenital Adrenal Hyperplasia Have Favorable Pregnancy Outcomes but Prolonged Time to Conceive. J Endocr Soc. 2024 Dec 6;9(1):bvae211. doi: 10.1210/jendso/bvae211. eCollection 2024 Nov 26. PMID: 39669654
Buffolo F, Pecori A, Reincke M, Outland M, Veglio F, Schwarzlmüller P, Bidlingmaier M, Kunz S, Stremmel C, Mengozzi G, Priolo G, Mulatero P, Adolf C, Monticone S. Long-Term Follow-Up of Patients With Elevated Aldosterone-to-Renin Ratio but Negative Confirmatory Test: The Progression of Primary Aldosteronism Phenotypes. Hypertension. 2024 Feb;81(2):340-347. doi: 10.1161/HYPERTENSIONAHA.123.21983. Epub 2023 Dec 12. PMID: 38084587
Clemmons DR, Bidlingmaier M. IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response. Eur J Endocrinol. 2024 Jul 2;191(1):R1-R8. doi: 10.1093/ejendo/lvae065. PMID: 38916798
Daneshpour H, Brüdgam D, Stüfchen I, Heinrich DA, Bidlingmaier M, Beuschlein F, Kürzinger L, Williams TA, Reincke M, Schneider H, Adolf C. Impact of confirmatory test results on subtype classification and biochemical outcome following unilateral adrenalectomy in patients with primary aldosteronism. Front Endocrinol (Lausanne). 2024 Nov 29;15:1495959. doi: 10.3389/fendo.2024.1495959. eCollection 2024. PMID: 39678193
Dubinski I, Bechtold-Dalla Pozza S, Bidlingmaier M, Hawley J, Keevil B, Kunz S, Nowotny HF, Reisch N, Schiergens K, Tschaidse L, Schmidt H. Diurnal 11-ketotestosterone and 17-hydroxyprogesterone saliva profiles in paediatric classical congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2024 Apr 2;37(5):419-424. doi: 10.1515/jpem-2024-0027. Print 2024 May 27. PMID: 38557593
Gadelha MR, Casagrande A, Strasburger CJ, Bidlingmaier M, Snyder PJ, Guitelman MA, Boguszewski CL, Buchfelder M, Shimon I, Raverot G, Tóth M, Mezősi E, Doknic M, Fan X, Clemmons D, Trainer PJ, Struthers RS, Krasner A, Biller BMK. Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. J Clin Endocrinol Metab. 2024 Dec 18;110(1):228-237. doi: 10.1210/clinem/dgae385. PMID: 38828555
Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S; Acromegaly Consensus Group. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024 Feb;27(1):7-22. doi: 10.1007/s11102-023-01360-1. Epub 2023 Nov 3. PMID: 37923946
Hirsch A, Adolf C, Stüfchen I, Beuschlein F, Brüdgam D, Bidlingmaier M, Reincke M, Quinkler M. NT-proBNP levels in patients with primary hyperaldosteronism and autonomous cortisol cosecretion. Eur J Endocrinol. 2024 Sep 30;191(4):444-456. doi: 10.1093/ejendo/lvae119. PMID: 39343731
Kunz S, Meng Y, Schneider H, Brunnenkant L, Höhne M, Kühnle T, Reincke M, Theodoropoulou M, Bidlingmaier M. Fast and reliable quantification of aldosterone, cortisol and cortisone via LC-MS/MS to study 11β-hydroxysteroid dehydrogenase activities in primary cell cultures. J Steroid Biochem Mol Biol. 2024 Nov;244:106610. doi: 10.1016/j.jsbmb.2024.106610. Epub 2024 Aug 28. PMID: 39214289
Laane L, Renner S, Kemter E, Stirm M, Rathkolb B, Blutke A, Bidlingmaier M, de Angelis MH, Wolf E, Hinrichs A. Decreased β-cell volume and insulin secretion but preserved glucose tolerance in a growth hormone insensitive pig model. Pituitary. 2024 Oct;27(5):567-576. doi: 10.1007/s11102-024-01424-w. Epub 2024 Jul 3. PMID: 38960990
Lecoq AL, Schilbach K, Rocher L, Trabado S, Briot K, Herrou J, Forbes A, Garnier A, Piketty M, Bidlingmaier M, Rothenbuhler A, Linglart A, Carette C, Chaumet-Riffaud P, Kamenický P. Metabolically healthy obesity in adults with X-linked hypophosphatemia. Eur J Endocrinol. 2024 Aug 5;191(2):156-165. doi: 10.1093/ejendo/lvae089. PMID: 39120742
Mansour N, Bruedgam D, Heinrich D, Dischinger U, Reisch N, Völter F, Stüfchen I, Nowak E, Zopp S, Vasileva V, Öcal O, Wildgruber M, Seidensticker M, Ricke J, Bidlingmaier M, Reincke M, Ribeiro de Oliveira Longo Schweizer J. Mild autonomous cortisol secretion leads to reduced volumetric BMD at lumbar spine in patients with primary aldosteronism. Front Endocrinol (Lausanne). 2024 Dec 12;15:1521680. doi: 10.3389/fendo.2024.1521680. eCollection 2024. PMID: 39726840
Mrosewski I, Dannheim V, Klett R, Urbank M, Stobbe S, Ittner JR, Bidlingmaier M. Rare coincidence: Macro-thyroid-stimulating hormone and multiple manufacturer-specific interferences in thyroid hormone immunoassays. Ann Clin Biochem. 2024 Nov;61(6):484-489. doi: 10.1177/00045632241262920. Epub 2024 Jun 21. PMID: 38906861
Nowak E, Vogel F, Braun L, Zopp S, Rubinstein G, Schilbach K, Bidlingmaier M, Zimmermann P, Thorsteinsdottir J, R O L Schweizer J, Ritzel K, Beuschlein F, Reincke M. Prevalence and outcome of secondary hypogonadism in male patients with Cushing's syndrome and mild autonomous cortisol secretion. Eur J Endocrinol. 2024 Aug 5;191(2):232-240. doi: 10.1093/ejendo/lvae097. PMID: 39074212
Nowotny HF, Zheng T, Seiter TM, Ju J, Schneider H, Kroiss M, Sarkis AL, Sturm L, Britz V, Lechner A, Potzel AL, Kunz S, Bidlingmaier M, Neuhaus K, Gottschlich A, Kobold S, Reisch N, Schirmer M, Reincke M, Adolf C. Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronism. Front Immunol. 2024 Dec 19;15:1428054. doi: 10.3389/fimmu.2024.1428054. eCollection 2024. PMID: 39749333
Schilbach K, Bidlingmaier M. Pitfalls in the lab assessment of hypopituitarism. Rev Endocr Metab Disord. 2024 Jun;25(3):457-465. doi: 10.1007/s11154-024-09881-1. Epub 2024 Apr 13. PMID: 38609701
Schluessel S, Bidlingmaier M, Martini S, Reincke M, Reisch N, Schaupp A, Stalla G, Teupser D, Schmidmaier R, Drey M. Hypogonadism is frequent in very old men with multimorbidity and is associated with anemia and sarcopenia. Z Gerontol Geriatr. 2024 Feb;57(1):43-49. doi: 10.1007/s00391-023-02235-7. Epub 2023 Sep 6. PMID: 37674061
Tausendfreund O, Bidlingmaier M, Martini S, Müller K, Rippl M, Schilbach K, Schmidmaier R, Drey M. Growth hormone treatment in aged patients with comorbidities: A systematic review. Growth Horm IGF Res. 2024 Apr;75:101584. doi: 10.1016/j.ghir.2024.101584. Epub 2024 Mar 9. PMID: 38489867
Vogel F, Braun L, Vetrivel S, Zhang R, Zopp S, Oßwald A, Nowak E, Schilbach K, Bidlingmaier M, Zimmermann P, Beuschlein F, Hartmann M, Wudy S, Riester A, Reincke M. Polymorphism in the Drug Transporter Gene ABCB1 as a Potential Disease Modifier in Cortisol-Producing Adrenal Adenomas. Exp Clin Endocrinol Diabetes. 2024 Nov;132(11):608-613. doi: 10.1055/a-2408-0718. Epub 2024 Sep 18. PMID: 39293469
Schilbach K, Raverot G. Does size really matter? A closer look at the absolute size of growth hormone-secreting pituitary adenomas. Pituitary. 2024 Oct;27(5):440-443. doi: 10.1007/s11102-024-01449-1. Epub 2024 Aug 30. PMID: 39212829.
Unger N, Theodoropoulou M, Schilbach K. Klinisch aktive Hypophysentumoren [Clinically active pituitary tumors]. Inn Med (Heidelb). 2024 Jul;65(7):672-680. German. doi: 10.1007/s00108-024-01729-9. Epub 2024 Jun 13. PMID: 38869654.
Wang K, Schober L, Fischer A, Bechmann N, Maurer J, Peischer L, Reul A, Hantel C, Reincke M, Beuschlein F, Robledo M, Mohr H, Pellegata NS, Schilbach K, Knösel T, Ilmer M, Angele M, Kroiss M, Maccio U, Broglie-Däppen M, Vetter D, Lehmann K, Pacak K, Grossman AB, Auernhammer CJ, Zitzmann K, Nölting S. Opposing effects of cannabidiol in patient-derived neuroendocrine tumor, pheochromocytoma/paraganglioma primary cultures. J Clin Endocrinol Metab. 2024 Apr 12:dgae241.
Störmann S, Meyhöfer SM, Groener JB, Faust J, Schilbach K, Seufert J, Vergès B. Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts' consensus statement. Front Endocrinol (Lausanne). 2024 Feb 9;15:1348990.
